Bonnie E Kirschenbaum

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
PURPOSE To discuss the role of restricted drug distribution systems in the implementation of risk evaluation and mitigation strategies (REMS), health-system pharmacists' concerns associated with the use of specialty pharmacies and other restricted drug distribution systems, reimbursement policies for high-cost specialty drugs, supply chain models for(More)
Task Force recommendations are discussed in more detail in eAppendix A (available at www.ajhp.org). What follows is a brief summary of those recommendations. In very abbreviated terms, the Task Force suggested that ASHP: 1. Consider creating and maintaining a Web resource center on ASHP's website to provide information about restricted drug distributions(More)
To deal with the changing health care landscape and the expanding growth of specialty pharmaceuticals, it is imperative that health systems evaluate their current structure of providing hospitalbased specialty pharmacy services. Specialty pharmacy services have rapidly expanded over the last decade, and this has affected a wide variety of disease states and(More)
  • 1